Unlock instant, AI-driven research and patent intelligence for your innovation.

CD133 antagonistic polypeptide as well as derivative and application thereof

A derivative and antagonistic technology, applied in the field of biotechnology and biomedicine, to achieve the effect of promoting apoptosis and huge social and economic benefits

Active Publication Date: 2020-09-11
SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

With the increasing research reports on tumor stem cell markers of colorectal cancer, CD44 / CD133 is currently a commonly used marker of tumor stem cells in colorectal cancer, and the high expression of CD44 / CD133 is a risk factor affecting the prognosis of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CD133 antagonistic polypeptide as well as derivative and application thereof
  • CD133 antagonistic polypeptide as well as derivative and application thereof
  • CD133 antagonistic polypeptide as well as derivative and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1: Panning, amplification, purification, sequencing and synthesis of CD133 antagonistic polypeptide HL12-CP5.

[0048] This example is mainly for the purpose of screening positive phages that specifically bind to CD133, and then by amplifying and purifying the positive phages, extracting phage single-stranded DNA (ssDNA) for sequencing, analyzing and comparing the obtained sequences, and finally synthesizing high-purity The antagonistic polypeptide HL12-CP5.

[0049] details as follows:

[0050] 1. Establishment of 293T cell line with permanent high expression of CD133: 293T-CD133 + / +

[0051] ①Select vigorously growing luminescent human 293T cells, and the day before transfection, use 5×10 5 cells / well, inoculated in a 6-well plate, cultured until the second day, the cell fusion degree was 60%;

[0052] ② Transfect on the second day, take one culture well of a 6-well plate as a unit, dilute 3 μg of plasmid with 200 μL of opti-MEM medium, and dilute 6 μL of ...

Embodiment 2

[0070] Example 2 Enzyme-linked immunosorbent assay detection of phage monoclonal binding to CD133

[0071] Firstly, a single clone of HL12-CP5 phage was picked, inoculated in LB medium containing ER2738, and cultured with shaking at 230 rpm for 7 hours at 37°C. Centrifuge at room temperature for 15 minutes at 5000 rpm, collect the supernatant and store at 4°C. 293T wild-type cells, 293TCD133 + / + cells, HCT-116 cells and HT-29 cells at 5×10 per well 3 seeded in 96-well plates and cultured for 24 hours. The next day, the cell culture medium was discarded, and blocking solution (DMEM+5%BSA) was added to each well to block for 2 hours. After discarding the blocking solution, add 100 μL of phage dilution solution (1:100) to each well for 2 hours. Then wash with PBST (PBS+0.1% Tween-20) 3 times, each time for 5min to remove unbound phage. Add 100 μL diluted (1:5000) peroxidase-linked anti-M13 phage antibody (purchased from GE) to each well, and let it react for 1 hour at room t...

Embodiment 3

[0072] Example 3 HL12-CP5 can significantly inhibit the proliferation of colorectal cancer cell HCT-116

[0073] ①The colorectal cancer cells HCT-116 were treated with 5×10 3 Each cell / well was inoculated in a 96-well cell culture plate with a medium volume of 200 μL in each well, cultured for 24 hours, and then starved overnight;

[0074] ② Add HL12-CP5 polypeptides with different concentration gradients (100 μM, 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM) and culture for 24 hours, 48 ​​hours, and 72 hours, respectively;

[0075] ③ Add 20 μL of MTT working solution to each well, and continue to culture in a carbon dioxide incubator for 4 hours;

[0076] ④ Discard the supernatant in the culture plate, add 150 μL DMSO (dimethyl sulfoxide), shake for 10 minutes, select a wavelength of 490 nm on a microplate reader for detection, and draw the growth curve of the cells.

[0077] In the previous work of the inventor's laboratory, it was found by q-PCR test that the colorectal cancer ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a CD133 antagonistic polypeptide as well as a derivative and application thereof, and specifically discloses the CD133 antagonistic polypeptide. An amino acid residue sequenceof the CD133 antagonistic polypeptide HL12-CP5 is represented by SEQ ID NO:1. A binding peptide and a derivative thereof are capable of binding with CD133 in vitro, and a downstream signal channel can be blocked through binding of the binding peptide and the derivative with the CD133, so that proliferation of colorectal cancer cells is inhibited, apoptosis of the colorectal cancer cells is accelerated, an effective therapeutic micromolecule drug is provided for colorectal cancer and the like, and the binding peptide and the derivative can be widely applied to the fields of medicines and biology.

Description

technical field [0001] The present invention relates to the field of biotechnology and biomedicine, specifically, the present invention is the colorectal cancer target CD133 receptor antagonistic polypeptide HL12-CP5 and its derivatives and applications. Background technique [0002] 1.1. Colorectal cancer [0003] Colorectal cancer (CRC) is one of the most common malignant tumors in the world. According to the report of the International Agency for Research on Cancer (IARC) of the World Health Organization, the incidence of colorectal cancer ranks third among malignant tumors after lung cancer and breast cancer, and the mortality rate ranks third among malignant tumors after lung cancer, liver cancer and gastric cancer. Tumor No. 4. The geographical distribution of colorectal cancer incidence has significant differences around the world, and the incidence rate in Europe and the United States is higher than that in Asia. The incidence of CRC in China is 29 / 100,000, and th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C12N15/11C07K16/00G01N33/68G01N33/574A61K38/10A61P35/00
CPCC07K7/08C07K16/00G01N33/6872G01N33/57484G01N33/57419G01N33/57446A61P35/00A61K38/00G01N2333/70596
Inventor 黄来强代小勇刘可为董璐吴佳敏冯春燕
Owner SHENZHEN GRADUATE SCHOOL TSINGHUA UNIV